Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis..
Anaerobe. 71, 102441.
(2021). Antigen-based immunotherapies do not prevent progression of recent-onset autoimmune diabetes: a systematic review and meta-analysis.
Endocrine. 541493253564319603435853315343646323232332378366375452107937693091093863(331029229844492951104144411978855372514249), 620 - 633.
(2016). Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus..
Rheumatol Int. 37(2), 293-298.
(2017). Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis..
BMJ. 361, k1310.
(2018). Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.
BMJ. k1310.
(2018). Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis..
Eur J Haematol. 98(6), 563-568.
(2017). Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis.
European Journal of Haematology. 98111125151171328622526459851317339343312102118301141312212432349259292117201512520158233100(6), 563 - 568.
(2017). Burden and Coping Strategies of Hypoglycemia in People with Diabetes..
Curr Diabetes Rev.
(2023). Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy..
Core Evid. 12, 1-10.
(2017). Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy.
Core Evidence. Volume 12, 1 - 10.
(2017). Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications..
Ther Adv Drug Saf. 7(2), 36-8.
(2016). Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.
Therapeutic Advances in Drug Safety. 7(2), 36 - 38.
(2016). Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes..
Ann Intern Med. 174(1), 141.
(2021). Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis..
Ann Intern Med. 173(4), 278-286.
(2020). Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis..
Diabetes Obes Metab. 23(3), 822-831.
(2021). Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis..
Hormones (Athens). 22(4), 655-664.
(2023). Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis..
Diabetes Obes Metab. 23(9), 2116-2124.
(2021). Complications of Diabetes 2017..
J Diabetes Res. 2018, 3086167.
(2018). Effect of epinephrine and insulin resistance on human monocytes obtained from lean and obese healthy participants: a pilot study..
Angiology. 62(1), 38-45.
(2011). Effect of glucose and insulin on oxidized low-density lipoprotein phagocytosis by human monocytes: a pilot study..
Angiology. 62(2), 163-6.
(2011). Effect of leptin and insulin resistance on properties of human monocytes in lean and obese healthy participants..
Angiology. 61(8), 768-74.
(2010). Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia..
Ann Intern Med. 163(3), 241.
(2015). Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis..
Diabetes Obes Metab. 25(10), 3020-3029.
(2023). Fixed ratio combinations of glucagon like peptide 1 receptor agonists with basal insulin: a systematic review and meta-analysis..
Endocrine. 56(3), 485-494.
(2017). Fixed ratio combinations of glucagon like peptide 1 receptor agonists with basal insulin: a systematic review and meta-analysis.
Endocrine. 5625815134372239371731583439396341596(31134341111109129114943), 485 - 494.
(2017).